| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Sourcebio International PLC
Sourcebio International PLC
LSE:SBI
Sourcebio International PLC
Common Shares Outstanding
Sourcebio International PLC
Common Shares Outstanding Peer Comparison
KOO
PHSC
TLY
MGP
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sourcebio International PLC
LSE:SBI
|
Common Shares Outstanding
£74.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kooth PLC
LSE:KOO
|
Common Shares Outstanding
£36.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
G
|
Genincode PLC
LSE:GENI
|
Common Shares Outstanding
£95.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PHSC PLC
LSE:PHSC
|
Common Shares Outstanding
£11.7m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
|
Totally PLC
LSE:TLY
|
Common Shares Outstanding
£196.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Medica Group PLC
LSE:MGP
|
Common Shares Outstanding
£122.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
See Also
What is Sourcebio International PLC's Common Shares Outstanding?
Common Shares Outstanding
74.2m
GBP
Based on the financial report for Dec 31, 2021, Sourcebio International PLC's Common Shares Outstanding amounts to 74.2m GBP.
What is Sourcebio International PLC's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 3Y
0%
Over the last year, the Common Shares Outstanding growth was 0%.
You don't have any saved screeners yet
